Globalspace Technologies Ltd

GlobalSpace Technologies Announces launch of PATGPT

Ready to deploy AI solution for Pharmaceutical Enterprises

Mumbai September 23, 2025, GlobalSpace Technologies Ltd announces the launch of PATGPT, a Pharma-specific Large Language Model (LLM) platform. PATGPT will operate under a hybrid model where 50% of the model training is already done by GlobalSpace on pharmaceutical datasets, and the remaining 50% will be trained using proprietary datasets of pharmaceutical companies within their own secure cloud environments.

This dual approach positions PATGPT as both a product and a customized LLM training service, enabling pharma companies to securely build organization-specific AI intelligence. In its initial phase, PATGPT will focus on sales, marketing, inventory, and distribution optimization. The future roadmap includes applications in R&D, clinical trials, pharmacovigilance, and regulatory submissions.


About GlobalSpace Technologies Ltd


GlobalSpace Technologies Ltd is a listed digital solutions company focused on the healthcare and pharmaceutical sectors. The company provides SaaS platforms and AI-powered solutions that enable pharma companies to digitize sales force operations, strengthen compliance, and enhance engagement with healthcare professionals.

“The launch of PATGPT marks a significant milestone in GlobalSpace’s journey towards becoming a leader in AI-driven healthcare solutions.” As quoted by Tania Mazumdar, Executive Director of GlobalSpace Technologies. By combining deep domain expertise with cutting-edge technology, GlobalSpace is creating sustainable value for its clients and stakeholders while opening new revenue streams through both product licensing and AI training services.

For further information, please contact:
GlobalSpace Technologies Ltd

Media Inquiries & Partnerships
Contact # 9321962944 ,email id: info@globalspace.in;